glp 1 linked to blindness Ozempic Lawsuit [2026 Update] Australian regulator warns of 'rare

Other links Review article advising resistance training in people taking GLP-1 agonists Paper that examines weight loss after 1 year of exercise or GLP-1 drugs More in-depth look at appetite and exercise behaviours in that study Study finding risk for RED-s in 30% of triathletes, including the tools that can be used to identify risk factors Cycling teams paying young riders big salaries More episodes View all episodes Why Anti-Doping Needs Target Testing and Investigation / Pogaar's Record Tour de France / The Weight-Loss Double Standard 01:10:38|Become a Supporter of The Real Science of Sport, and for the price of a coffee, or a gel, you get a bonus Applied episode every week, ad-free shows, and the best cycling and running community going over on Discourse.Show notesThis week we recap Tadej Pogaar's record-breaking Tour de France, and then get into the meat of it: why anti-doping leans so heavily on investigation and targeted testing, with insights from our interview with Brett Clothier, head of athletics' Athletics Integrity Unit.(02:24) Tadej Pogaar wins a fifth Tour de France in what Ross reckons is the most dominant display he has seen in any sport, and we dig into the numbers behind it, including an estimated 7 W/kg on Alpe d'Huez that obliterates Pantani's old mark, why the yellow jersey was effectively settled by stage six, and why the racing everywhere else still made it a decent watch.(13:55) The weight-loss double standard

Thanks to its cytoprotective effects in the GI tract , BPC-157 is being explored as a therapy for inflammatory bowel diseases like Crohns disease and ulcerative colitis

Today, the majority of the emerging GIP receptor targeting compounds are claimed to be agonists, and to increase insulin secretion (17, 20), to improve insulin sensitivity (91), and also, suppress appetite (119)

Injection site reactions with BPC-157 occur in roughly 4-6% of patients, generally milder than those observed with KPV

We are also grateful to our colleagues and collaborators for their invaluable in-sights and support throughout this article

Determining when to stop depends on the specific medication, as they each stay in the body for different lengths of time